3,984 followers
7/ One of the clinical trials I worked on was high dose IL-2 (Proleukin) in stage III and IV melanoma patients. According to the linked article, the complete response rate is around 3% for this therapy. https://t.co/PlzMNkHCAo
7/ One of the clinical trials I worked on was high dose IL-2 (Proleukin) in stage III and IV melanoma patients. According to the linked article, the complete response rate is around 3% for this therapy. https://t.co/PlzMNkHCAo
#JITC: A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma https://t.co/o5Ry6ZbNwa